Bellerophon Therapeutics (BLPH) Tops Q3 EPS by 6c

Bellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.53), $0.06 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• DAM Capital Starts Centum Electronics (CTE:IN) at Buy